The latest funding builds off a Series B announced in April.
Value-based care startup Vytalize Health garnered a whopping $100 million in funding. Monroe Capital and Enhanced Healthcare Partners led the round, with participation from North Coast Ventures.
WHAT IT DOES
Vytalize Health offers independent primary care practices treating Medicare patients a value-based care platform with data analytics, including data about their patients, practice, enrollment and finances.
The company also provides its clients with a virtual in-home clinic that collaborates with the private practice to help manage high-risk populations.
“We have a responsibility to ensure the ongoing success of value-based care by building high-performing systems of care that truly advance quality, improve the patient experience, and are sustainable for providers and the system overall.
“We believe primary care is a key part of the delivery system and that we must protect and reward independent primary care physicians who deliver more data-driven and effective care to patients. In this outcome-based environment, we can focus on real, proactive health care vs. sick care and align our model with what’s better for patients,” Faris Ghawi, Vytalize Health cofounder and CEO, said in a statement.
RELATED: MDI Health Raises $20 Million Series A to Tackle Medication-Related Problems
MARKET SNAPSHOT
Medicare Advantage models that focus on value-based care have been shown to be more efficient and provide better patient outcomes, according to a study commissioned by Optum. Investors have also become more attracted to providers specializing in value-based care.
In April, Vytalize Health announced it had scored $50 million in Series B funding. In 2021, the company acquired MedPilot, a patient financial engagement platform.
Other companies aiming to improve value-based care include Aledade, which recently purchased analytics platform Curia, and Pearl Health, a technology platform for primary care practices in value-based care arrangements.
